By Illana Goldfinger, Life Sciences practice group leader While many brokers lament the “soft market” and excess capacity across most commercial lines, the picture looks quite different in Life Sciences, especially in biotech. D&O premiums continue to climb, and markets willing to take on this class of risk are shrinking. So, what’s driving this trend?… Read More
Life Sciences
How changes in vaccine guidelines are affecting risk exposure
by Illana Goldfinger, Life Sciences Practice Group Leader Recent changes to federal vaccine guidelines are introducing new uncertainty across the insurance and liability landscape. As recommendations shift toward shared clinical decision‑making and more individualized care, long‑standing assumptions about standards of care, coverage, and risk allocation are being reevaluated. Our Life Sciences Practice Group leader, Illana… Read More
Staying ahead of Life Sciences risk
Bridge Specialty Group holds market recognition that enables us to connect retail partners with tailored insurance solutions, and we do that through our specific practice groups including Property, Casualty, Environmental, Executive Risk, Farm & Ranch, Healthcare, Life Sciences, Personal Lines, Public Entity, Transportation and Workers’ Compensation. As we continue to expand our products and capabilities… Read More
How the life sciences sector is forcing insurance to innovate
Life sciences market overview The life sciences industry focuses on improving the health and well-being of people, animals and the environment. It includes companies and organizations that study how living things work and develop new medicines, medical devices and technologies to treat diseases and enhance quality of life. From discovering new treatments to producing vaccines… Read More
